Maastricht University Medical Center+ or Maastricht UMC+ is an academic hospital in the city of Maastricht and affiliated with Maastricht University. Maastricht UMC+ is one of the eight university medical centers in the Netherlands and is part of Netherlands Federation of University Medical Centres

There are 715 beds in Maastricht University Medical Centre; Dermatologie.

During the past decade, Maastricht University Medical Centre; Dermatologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Maastricht University Medical Centre; Dermatologie" are "Basal Cell Carcinoma" (2 trials). Many other conditions were trialed in "Maastricht University Medical Centre; Dermatologie" in a lesser frequency.

Most popular intervention types in "Maastricht University Medical Centre; Dermatologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Vismodegib" (1 trials) and "vismodegib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maastricht University Medical Centre; Dermatologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Maastricht University Medical Centre; Dermatologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Maastricht University Medical Centre; Dermatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maastricht University Medical Centre; Dermatologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".